NCT02563886

Brief Summary

The purpose of this study is to determine whether intensive, focused training of the affected upper extremity after stroke results in long-term functional gains in moderately-to-severely paralyzed patients, more than 6 months after their vascular accident. During the course of therapy, user's attempts to move and complete exercises are assisted by neuromuscular electrical stimulation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2015

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

September 22, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 30, 2015

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

February 24, 2016

Status Verified

February 1, 2016

Enrollment Period

1 year

First QC Date

September 22, 2015

Last Update Submit

February 23, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Fugl-Meyer Assessment of the Upper Extremity (FMA-UE),

    A quantitative measure of motor impairment.

    T0 (Before treatment); T1 (3 weeks after start and before treatment crossover); T2 (6 weeks after T0, at the end of treatment); T3 (3 months after treatment); T4 (6 months after treatment)

Secondary Outcomes (4)

  • Wolf Motor Function Test

    T0 (Before treatment); T1 (3 weeks after start and before treatment crossover); T2 (6 weeks after T0, at the end of treatment); T3 (3 months after treatment); T4 (6 months after treatment)

  • Modified Ashworth scale

    T0 (Before treatment); T1 (3 weeks after start and before treatment crossover); T2 (6 weeks after T0, at the end of treatment); T3 (3 months after treatment); T4 (6 months after treatment)

  • European stroke scale

    T0 (Before treatment); T1 (3 weeks after start and before treatment crossover); T2 (6 weeks after T0, at the end of treatment); T3 (3 months after treatment); T4 (6 months after treatment)

  • Motor Activity Log

    T0 (Before treatment); at 1, 2, 3, 4, 5, 6, 18 and 30 weeks after treatment start

Study Arms (2)

EAMT, then standard care

EXPERIMENTAL

Electrically Assisted Movement Therapy precedes usual and customary care.

Other: Electrically Assisted Movement TherapyOther: Usual and customary care

Standard care, then EAMT

ACTIVE COMPARATOR

Usual and customary care precedes Electrically Assisted Movement Therapy.

Other: Electrically Assisted Movement TherapyOther: Usual and customary care

Interventions

Electrically Assisted Movement Therapy (EAMT) is an extension of conventional Constraint-Induced Movement Therapy (CIMT) for moderately-to-severely paralyzed patients. During EAMT, patients use a movement controller with the healthy hand, controlling movements generated through neuromuscular electrical stimulation of the paralyzed arm and hand. During each session three types of exercises can be performed: mobilization, games, and training for activities of daily living, all three involving proper shaping of exercise difficulty at therapist discretion. Therapy consists in 20 sessions of 45 minutes twice per day over five weeks.

Also known as: EAMT
EAMT, then standard careStandard care, then EAMT

Usual and customary care ranges from no treatment to varying amounts of orthotics, home-based and clinic-based occupational therapy, or physiotherapy, but always excludes CIMT and EAMT. Therapy consists in 20 sessions of 45 minutes twice per day over five weeks, whenever possible, to match EAMT amount of therapy.

Also known as: Standard care
EAMT, then standard careStandard care, then EAMT

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of one, first ever stroke (both ischemic or hemorrhagic) verified by brain imaging (MRI or CT);
  • Chronic impairment after stroke (minimum 6 months);
  • No contraindications to MRI;
  • No contraindications to electrical stimulation;

You may not qualify if:

  • Unstable recovery stage (difference between two examinations \> 1 FMA-UE point);
  • Mild impairment of the upper extremity (FMA-UE \>= 21);
  • Excessive spasticity of the affected arm (modified Ashworth Scale \> 2);

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de Neuropsychologie et neuroréhabilitation - CHUV

Lausanne, Canton of Vaud, 1011, Switzerland

Location

Related Publications (1)

  • Carda S, Biasiucci A, Maesani A, Ionta S, Moncharmont J, Clarke S, Murray MM, Millan JDR. Electrically Assisted Movement Therapy in Chronic Stroke Patients With Severe Upper Limb Paresis: A Pilot, Single-Blind, Randomized Crossover Study. Arch Phys Med Rehabil. 2017 Aug;98(8):1628-1635.e2. doi: 10.1016/j.apmr.2017.02.020. Epub 2017 May 9.

MeSH Terms

Conditions

Stroke

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Stefano Carda, MD, PhD

    Neuropsychology and Neurorehabilitation Service, Centre hospitalier universitaire vaudois (CHUV)

    PRINCIPAL INVESTIGATOR
  • José del R. Millán, Prof.

    Defitech Foundation Chair in Brain-machine Interface, Swiss Federal Institute of Technology Lausanne (EPFL)

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

September 22, 2015

First Posted

September 30, 2015

Study Start

September 1, 2015

Primary Completion

September 1, 2016

Study Completion

December 1, 2016

Last Updated

February 24, 2016

Record last verified: 2016-02

Data Sharing

IPD Sharing
Will not share

Locations